Epirubicin HCL Injection is a potent anthracycline-based chemotherapy drug, often used in combating various types of cancer. It is a semi-synthetic derivative of doxorubicin, made soluble and stable through its hydrochloride salt form, enabling secure intravenous administration. Common applications include:
Epitubicin HCL Injection is a proven, efficient chemotherapeutic agent used in cancer treatment. It's significant in managing diverse types of cancers, particularly breast cancer, gastric cancer, lung cancer, and lymphomas.
Epitubicin HCL Injection works by intercalating DNA, inhibiting the enzyme topoisomerase II and producing complex radicals that damage the DNA, causing cell death and diminishing cancer growth.
Please note, this product is strictly to be used under medical supervision. Side effects can occur, and drug interactions are possible. Be keen to follow all professional medical advice concerning the dosage and treatment duration. Contraindications include known hypersensitivity to Epirubicin, severe myocardial insufficiency, recent myocardial infarction, severe arrhythmias, previous treatments with high doses of Epitubicin and severe liver disease.